Catasys (CATS) Rating Lowered to Hold at Zacks Investment Research

Catasys (NASDAQ:CATS) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Monday.

According to Zacks, “Catasys, Inc., formerly known as Hythiam, Inc., provides specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Company’s program seeks to improve member health by delivering medical and psychosocial interventions in combination with long term care coaching, including their proprietary treatment program for alcoholism and stimulant dependence. Catasys, Inc. is based in Los Angeles. “

A number of other research analysts also recently issued reports on the stock. TheStreet downgraded shares of Catasys from a “c” rating to a “d+” rating in a research report on Wednesday, December 26th. ValuEngine downgraded shares of Catasys from a “strong-buy” rating to a “buy” rating in a research report on Monday, February 4th.

NASDAQ CATS opened at $12.12 on Monday. The firm has a market cap of $195.62 million, a P/E ratio of -14.26 and a beta of 1.82. Catasys has a 1 year low of $4.03 and a 1 year high of $14.29.

Catasys (NASDAQ:CATS) last posted its earnings results on Wednesday, November 14th. The company reported ($0.27) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.02. The business had revenue of $4.37 million for the quarter, compared to analyst estimates of $4.00 million. Equities analysts anticipate that Catasys will post -1.05 EPS for the current fiscal year.

Several institutional investors have recently modified their holdings of CATS. Essex Investment Management Co. LLC acquired a new position in shares of Catasys in the third quarter worth about $1,255,000. Engineers Gate Manager LP acquired a new position in shares of Catasys in the third quarter worth about $139,000. JPMorgan Chase & Co. raised its position in shares of Catasys by 205.5% in the third quarter. JPMorgan Chase & Co. now owns 10,418 shares of the company’s stock worth $134,000 after acquiring an additional 7,008 shares during the period. Ancora Advisors LLC acquired a new position in shares of Catasys in the third quarter worth about $191,000. Finally, Uniplan Investment Counsel Inc. acquired a new position in shares of Catasys in the third quarter worth about $3,511,000. Institutional investors and hedge funds own 10.45% of the company’s stock.

Catasys Company Profile

Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.

Featured Story: Hedge Funds – Risk or Reward?

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.